Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-05-27 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BARBERAZ (73000), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES ARUMS : revenue, balance sheet and financial ratios
PHARMACIE DES ARUMS is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BARBERAZ (73000),
this company of category PME
shows in 2024 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES ARUMS (SIREN 820634517)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
1 562 371 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
45 390 €
36 369 €
26 257 €
46 856 €
30 433 €
53 434 €
45 623 €
73 082 €
EBITDA
N/C
51 927 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
2.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES ARUMS generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 73 k€ -> 45 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 390 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.499%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.158%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
300.572
220.181
173.286
135.956
108.19
82.609
60.03
40.499
Financial autonomy
21.727
27.177
30.762
36.64
40.274
46.868
51.631
58.158
Repayment capacity
None
None
None
None
None
None
5.613
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
2.711%
None%
Sector positioning
Debt ratio
40.52025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-10 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES ARUMS (40.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
58.16%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+8 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES ARUMS (58.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.61 years2024
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of PHARMACIE DES ARUMS (5.61) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 123.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
123.978
Liquidity indicators evolution PHARMACIE DES ARUMS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
161.764
161.4
190.611
194.729
153.772
141.063
130.845
123.978
Interest coverage
None
None
None
None
None
None
7.511
None
Sector positioning
Liquidity ratio
123.982025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch
In 2025, the liquidity ratio of PHARMACIE DES ARUMS (123.98) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
7.51x2024
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Good
In 2024, the interest coverage of PHARMACIE DES ARUMS (7.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES ARUMS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
77 978 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
22
0
Customer payment term (days)
0
0
0
0
0
0
7
0
Supplier payment term (days)
0
0
0
0
0
0
20
0
Positioning of PHARMACIE DES ARUMS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES ARUMS is estimated at
721 025 €
(range 489 291€ - 1 131 388€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
489k€721k€1131k€
721 025 €Range: 489 291€ - 1 131 388€
NAF 5 année 2025
Valuation method used
Net Income Multiple
45 390 €
×
15.9x
=721 026 €
Range: 489 291€ - 1 131 388€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES ARUMS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES ARUMS
What is the revenue of PHARMACIE DES ARUMS ?
The revenue of PHARMACIE DES ARUMS in 2024 is 1.6 M€.
Is PHARMACIE DES ARUMS profitable?
Yes, PHARMACIE DES ARUMS generated a net profit of 45 k€ in 2025.
Where is the headquarters of PHARMACIE DES ARUMS ?
The headquarters of PHARMACIE DES ARUMS is located in BARBERAZ (73000), in the department Savoie.
Where to find the tax return of PHARMACIE DES ARUMS ?
The tax return of PHARMACIE DES ARUMS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES ARUMS operate?
PHARMACIE DES ARUMS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart